Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Oncology Letters|August 7, 2012
Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancerYasutoshi Kuboki, Nobuyuki Mizunuma, Masato Ozaka, et al.
International Journal of Clinical Oncology|April 1, 2021
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapyTsuyoshi Takeda, Takashi Sasaki, Chisaki Suzumori, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 15, 2020
Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: Intention-to-treat analysis compared with upfront surgeryYosuke Inoue, Akio Saiura, Atsushi Oba, et al.
DEN Open|January 13, 2023
The efficacy and safety of a duckbill-type anti-reflux metal stent as the initial metal stent for distal malignant biliary obstruction in unresectable pancreatic cancerTsuyoshi Takeda, Takashi Sasaki, Yuto Yamada, et al.
BMC Cancer|October 23, 2015
Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?Hiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, et al.
International Journal of Clinical Oncology|November 11, 2020
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patientsTsuyoshi Takeda, Takashi Sasaki, Koshiro Fukuda, et al.
Medicine|January 20, 2021
Prospective study of EUS-guided tissue acquisition with a 20G core biopsy needle with a forward bevel for solid pancreatic massRyo Kanata, Takashi Sasaki, Masato Matsuyama, et al.
Pancreas|May 3, 2021
Comparison of Treatment Outcomes Between Gemcitabine With Nab-Paclitaxel and Modified FOLFIRINOX for First-Line Chemotherapy in Metastatic and Recurrent Pancreatic Cancer: Propensity Score MatchingTakafumi Mie, Takashi Sasaki, Tsuyoshi Takeda, et al.
DEN Open|April 11, 2024
Outcomes of 6-mm diameter fully covered self-expandable metal stents for preoperative biliary drainage in pancreatic cancerHiroki Nakagawa, Tsuyoshi Takeda, Takeshi Okamoto, et al.
Annals of Gastroenterological Surgery|November 6, 2023
Re-appraisal of the universal definition of tumor rupture among patients with high-risk gastrointestinal stromal tumorsNaoto Gotohda, Toshirou Nishida, Shinsuke Sato, et al.
Pageof 18